Mark Hatley

Dr. Mark Hatley, a leading researcher in pediatric oncology from St. Jude Children’s Research Hospital, dives deep into the genetic underpinnings of childhood cancers such as rhabdomyosarcoma. He unpacks how the PAX3-FOXO1 and DICER1 genes contribute to tumor formation. The discussion highlights the critical shift from animal models to human systems in cancer research, providing fresh insights into potential treatments. Hatley emphasizes the importance of understanding developmental biology to uncover innovative strategies for combating pediatric cancer.